
Keywords: aCL; anticardiolipin; anti-β2GPI; anti-β2-glycoprotein I; aPLs; antiphospholipid antibodies; APS; antiphospholipid syndrome; BBB; blood-brain barrier; CGRP; calcitonin gene-related peptide; CI; confidence interval; DRVVT; dilute Russell's viper venom te